BMSN 3rd Quarter April, May & June
FDA Approval This Month 30 Days From March 18, 2013 FDA IND # Issued
4th Quarter July, August & September
Initiate HemaXellerate Trials
File IND # on Min Technology:
Initiate Clinical Trial on Min Technology
Sec Filing: UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 10-K
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Year Ended September 30, 2012
File Number: 0-32201
BIO-MATRIX SCIENTIFIC GROUP, INC.
(Exact name of registrant as specified in its charter)
DELAWARE 33-0824714 (State of jurisdiction of Incorporation) (I.R.S. Employer Identification No.)
4700 SPRING STREET, SUITE 304, LA MESA, CALIFORNIA, 91942 (Address of principal executive offices) (Zip Code)
(619) 702-1404
(Registrants telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Exchange Act:
Thanks Brother 'Ulfahl' |